https://meksignaling.com/index.....php/inferring-a-who
Methods From April 2013 to May 2017, 331 patients from 22 hospitals who had been pathologically verified with stage ⅢA-ⅣA ESCC were randomized to 60 Gy or 50 Gy with arbitrary number table. Complete of 305 patients were reviewed, including 152 in 60 Gy team and 153 in 50 Gy group. The median age had been 63 many years, 242(79.3%) males and 63(20.7%) females. The median period of primary tumefaction was 5.6 cm. The clinical characteristics between two groups w
Like
Comment
Share
